James Gilhool, DO
Interventional Pain Medicine · York, PANPI 1295700599
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 34 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 8 manufacturers reported payments, led by Boston Scientific at 35.5% of the total. Reporting peaked in 2024 at $551 and has fallen 63.0% since, to $204 in 2025. That places this record below the midpoint for interventional pain medicine clinicians in PA, where the typical reported total is $2,714.
Across 34 payments — averaging $52.29 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Boston Scientific$631
- Vertiflex, Inc.$221
- Abbott$217
- Relievant Medsystems, Inc.$215
- Vertos Medical, Inc.$178
- Medtronic$148
- plus $168 from 2 others
What the payments were for
- Food & beverage$1,778100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Boston Scientific | 13 | $631 |
| Vertiflex, Inc. | 4 | $221 |
| Abbott | 7 | $217 |
| Relievant Medsystems, Inc. | 3 | $215 |
| Vertos Medical, Inc. | 2 | $178 |
| Medtronic | 2 | $148 |
| AstraZeneca | 1 | $122 |
| Si-bone, Inc. | 2 | $46 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$1,778 in reported general payments places this provider in the 45th percentile of 59 interventional pain medicine providers in Pennsylvania.
See all interventional pain medicine providers in Pennsylvania →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Gabapentin | 677 | $7,559 |
| Pregabalin | 72 | $2,626 |
| Celecoxib | 49 | $1,651 |
| Diclofenac Sodium | 150 | $1,412 |
| Fentanyl | 16 | $1,335 |
| Meloxicam | 340 | $1,083 |
| Cyclobenzaprine Hcl | 146 | $872 |
| Tizanidine Hcl | 21 | $592 |
| Carisoprodol | 26 | $422 |
| Tramadol Hcl | 62 | $271 |
| Acetaminophen-CodeineAcetaminophen With Codeine | 33 | $263 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 25 | $250 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 16 | $202 |
| Methocarbamol | 21 | $138 |
| Oxycodone Hcl | 14 | $96 |
Paid to pharmacies, not to this prescriber.
Other interventional pain medicine in York
- Michael FurmanYork$5K
- Earl EdwardsYork$58
- Michael FishmanLebanon$670K
- David ProvenzanoSewickley$198K
- Michael FarrellPittsburgh$23K
- Farshad RashidianWest Chester$19K
- Chad MetzgerDarby$14K
- Jorge Rivero-BecerraPittsburgh$12K
- James BresnahanSpringfield$12K
- Jonathan SchollIndiana$11K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.